FISCAL NOTE



FUND(S):

0588, 2154, 8838

Sources of Revenue:

General Fund,Other Fund Federal funds

Legislation creates:

Neither Program nor Fund



Fiscal Note Summary


Effect this measure will have on costs and revenues of state government.


This bill would add language to West Virginia Code 60A-10-7 to require a lawful prescription for dispensing drug products containing ephedrine, pseudoephedrine, phenylpropanolamine, and other chemical presursors of methamphetamine as active ingredients. CHIP cannot determine the fiscal impact of this bill but believes it would be very minimal on CHIP expenditures; 1) it has not been determined whether or not the program would cover these medications once this change is made (CHIP does not cover over-the-counter prescriptions); 2) of the approximately 30,000 monthly sales it cannot determine how many are for children; 3) CHIP members would be a very small share of this 30,000; and 4) many members would switch to an over-the-counter alternative to avoid additional expense of visiting a physician for a prescription (members have copayments for office visits).



Fiscal Note Detail


Effect of Proposal Fiscal Year
2011
Increase/Decrease
(use"-")
2012
Increase/Decrease
(use"-")
Fiscal Year
(Upon Full
Implementation)
1. Estmated Total Cost 0 0 0
Personal Services 0 0 0
Current Expenses 0 0 0
Repairs and Alterations 0 0 0
Assets 0 0 0
Other 0 0 0
2. Estimated Total Revenues 0 0 0


Explanation of above estimates (including long-range effect):






Memorandum


This bill would add language to West Virginia Code 60A-10-7 to require a lawful prescription for dispensing drug products containing ephedrine, pseudoephedrine, phenylpropanolamine, and other chemical presursors of methamphetamine as active ingredients. CHIP cannot determine the fiscal impact of this bill but believes it would be very minimal on CHIP expenditures; 1) it has not been determined whether or not the program would cover these medications once this change is made (CHIP does not cover over-the-counter prescriptions); 2) of the approximately 30,000 monthly sales it cannot determine how many are for children; 3) CHIP members would be a very small share of this 30,000; and 4) many members would switch to an over-the-counter alternative to avoid additional expense of visiting a physician for a prescription (members have copayments for office visits).



    Person submitting Fiscal Note: Stacey L. Shamblin
    Email Address: Stacey.L.Shamblin@wv.gov